- Home
- ZLAB vs DAVE Comparison
ZLAB vs DAVE Comparison
Compare ZLAB & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- DAVE
- Stock Information
- Founded
- ZLAB 2013
- DAVE 2017
- Country
- ZLAB China
- DAVE United States
- Employees
- ZLAB N/A
- DAVE N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- ZLAB Health Care
- DAVE Technology
- Exchange
- ZLAB Nasdaq
- DAVE Nasdaq
- Market Cap
- ZLAB 3.6B
- DAVE 3.2B
- IPO Year
- ZLAB 2017
- DAVE N/A
- Fundamental
- Price
- ZLAB $32.91
- DAVE $203.03
- Analyst Decision
- ZLAB Buy
- DAVE Strong Buy
- Analyst Count
- ZLAB 6
- DAVE 6
- Target Price
- ZLAB $57.22
- DAVE $265.50
- AVG Volume (30 Days)
- ZLAB 725.2K
- DAVE 411.5K
- Earning Date
- ZLAB 11-11-2025
- DAVE 11-11-2025
- Dividend Yield
- ZLAB N/A
- DAVE N/A
- EPS Growth
- ZLAB N/A
- DAVE 70.95
- EPS
- ZLAB N/A
- DAVE 3.84
- Revenue
- ZLAB $427,799,000.00
- DAVE $433,065,000.00
- Revenue This Year
- ZLAB $41.60
- DAVE $48.07
- Revenue Next Year
- ZLAB $53.42
- DAVE $15.28
- P/E Ratio
- ZLAB N/A
- DAVE $52.79
- Revenue Growth
- ZLAB 32.56
- DAVE 47.97
- 52 Week Low
- ZLAB $23.70
- DAVE $37.44
- 52 Week High
- ZLAB $44.34
- DAVE $286.45
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.59
- DAVE 44.12
- Support Level
- ZLAB $33.76
- DAVE $195.74
- Resistance Level
- ZLAB $34.72
- DAVE $245.24
- Average True Range (ATR)
- ZLAB 0.86
- DAVE 12.38
- MACD
- ZLAB 0.20
- DAVE -2.78
- Stochastic Oscillator
- ZLAB 51.19
- DAVE 16.40
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.